Emerg Infect Dis 2007, 13:1121–1123.PubMedCrossRef 40. Cloeckaert A, Praud K, Doublet B, Bertini A, Carattoli

A, Butaye P, Imberechts H, Bertrand S, Collard JM, Arlet G, Weill FX, Nakaya R: Dissemination of an extended-spectrum-beta-lactamase blaTEM-52 gene-carrying IncI1 plasmid in various KU57788 Salmonella enterica Selleckchem MAPK inhibitor serovars isolated from poultry and humans in Belgium and France between 2001 and 2005. Antimicrob Agents Chemother 2007, 51:1872–1875.PubMedCrossRef 41. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR: Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61:273–281.PubMedCrossRef 42. Bae IK, Lee YN, Lee WG, Lee SH, Jeong SH: Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene. Antimicrob Agents Chemother 2007, 51:3017–3019.PubMedCrossRef 43. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A: Replicon typing of plasmids carrying VS-4718 price CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006, 50:3203–3206.PubMedCrossRef 44. Cowan ST: Cowan and Steel’s manual for identification of medical bacteria. 2nd edition. Cambridge University Press, Cambridge;

1985. 45. Clinical and Laboratory Standards Institute (CLSI): Performance standardsfor antimicrobial Liothyronine Sodium susceptibility testing; 15th informational supplement (M100-S15). Clinical Laboratory Standards Institute, Wayne PA, USA: CLSI; 2007. 46. Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N: Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom. J Antimicrob Chemother 2006, 58:665–668.PubMedCrossRef 47. Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA: Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. J Infect Dev Ctries 2007,

1:257–262.PubMed 48. Arlet G, Rouveau M, Philippon A: Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum beta-lactamase. FEMS Microbiol Lett 1997, 152:163–167.PubMedCrossRef 49. Arlet G, Brami G, Decre D, Flippo A, Gaillot O, Lagrange PH, Philippon A: Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett 1995, 134:203–208.PubMed 50. Lartigue MF, Poirel L, Nordmann P: Diversity of genetic environment of bla(CTX-M) genes. FEMS Microbiol Lett 2004, 234:201–207.PubMedCrossRef 51. Winokur PL, Brueggemann A, DeSalvo DL, Hoffmann L, Apley MD, Uhlenhopp EK, Pfaller MA, Doern GV: Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.